Skip to main content

Specialty Pharmacy

  • BioScrip utilizes HealthyCircles platform for website

    ELMSFORD, N.Y. — Specialty pharmacy provider BioScrip has launched a Web service designed to connect healthcare professionals, patients and caregivers in order to help patients manage their medications and improve their overall care experience.

    The website, myBioScrip.com, uses HealthyCircles, an online platform that enables people to use manage and share health information.

  • Medco's Q4, fiscal-year sales rise

    FRANKLIN LAKES, N.J. — Sales at Medco Health Solutions increased to $16.9 billion during fourth quarter 2010 and to $66 billion for the fiscal year as a whole, representing respective 11.1% and 10.3% increases over the same periods the year before, the pharmacy benefit manager said Tuesday.

    Profits for the quarter were $378.5 million, a 10.8% increase over fourth quarter 2009, while profits for the year were $1.4 billion, an 11.5% increase over fiscal year 2009.

  • BP kiosk uploads data to EHR

    ROCHESTER, N.Y. — Blood-pressure kiosks have become a ubiquitous site in retail pharmacies across the country, but like pharmacy automation and technology as a whole, they’re continuing to advance and offer new features.

  • FDA OKs Corifact

    SILVER SPRING, Md. — The Food and Drug Administration has approved a treatment for a rare bleeding disorder.

    The FDA announced the approval of Corifact, used to prevent bleeding in people with the genetic disorder congenital Factor XIII deficiency, which affects 1-in-3 million to 5 million people in the United States.

    The drug is manufactured by Marburg, Germany-based CSL Behring.

  • Tech, interconnectivity 
focus of NCPDP summit

    Technology is not only bringing more benefits to patients in the pharmacy, but it’s also offering them a host of products so they can be more involved in their health care. This was a theme at the National Council for Prescription Drug Programs’ educational summit, “Leveraging New Technologies: Impact on the Patient and the Healthcare Industry,” on Feb. 8 in Las Vegas.


  • Report: Exclusivity period for biotech drugs may be reduced to seven years

    WASHINGTON — The Obama administration’s proposed budget for 2012 contains an item that could change the game for biosimilars, according to published reports.

    According to the reports, the administration would lower the 12-year data exclusivity period for biotech drugs mandated in the healthcare-reform law to seven years.

  • Sean Whelan named Diplomat's new CFO

    FLINT, Mich. — Diplomat Specialty Pharmacy has hired a new CFO, the company said.

    Diplomat announced the appointment of Sean Whelan, citing his experience as a CFO in the healthcare industry. Whelan will report directly to president and CEO Phil Hagerman.

  • Savient announces executive appointments

    EAST BRUNSWICK, N.J. — Savient Pharmaceuticals announced changes to its management team as it gears up for the commercial launch of its chronic gout treatment.

    The drug maker appointed Louis Ferrari as its SVP corporate development, Christine Mikail as SVP and Stephen Davies as chief information officer and group VP.

X
This ad will auto-close in 10 seconds